MARKET

DXR

DXR

DAXOR CORP
AMEX

Real-time Quotes | Nasdaq Last Sale

11.08
0.00
0.00%
Closed 16:00 09/21 EDT
OPEN
11.04
PREV CLOSE
11.08
HIGH
11.08
LOW
11.04
VOLUME
950
TURNOVER
--
52 WEEK HIGH
17.58
52 WEEK LOW
8.58
MARKET CAP
44.70M
P/E (TTM)
140.61
1D
5D
1M
3M
1Y
5Y
BRIEF-Daxor Corp Presents New Data Validating the Benefit of BVA-100 Blood Test for Heart Failure Patients
reuters.com · 09/14 12:52
Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Heart Failure Patients at Key Scientific Society Meeting
Data from Three New Studies and Two Ongoing Trials Presented at the Heart Failure Society of America Annual Scientific Meeting 2021 Data Highlight Importance of Blood Volume Analysis in Providing Appropriate, Personalized Care to Patients with Heart Failur...
GlobeNewswire · 09/14 12:30
Daxor Corporation To Present New Data, Clinical Trials Utilizing BVA-100 Blood Test At Heart Failure Society Of America Annual Scientific Meeting 2021
Daxor Corporation (NYSE:DXR), the global leader in blood volume measurement technology, , today announced it will exhibit at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2021
Benzinga · 09/08 12:50
Daxor Corporation To Present Compelling New Data and Clinical Trials Utilizing the BVA-100® Blood Test at the Heart Failure Society of America Annual Scientific Meeting 2021
Oak Ridge, TN, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, , today announced it will exhibit at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2021...
GlobeNewswire · 09/08 12:30
Daxor Corporation to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
Oak Ridge, TN, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE:DXR), the global leader in blood volume measurement technology, today announces that President and Chief Executive Officer Michael Feldschuh will present at the 23rd Annual H.C. Wain...
GlobeNewswire · 09/07 12:30
Daxor Corporation CEO And President Michael Feldschuh Provides Corporate Update In Letter To Shareholders
Daxor Corporation (NYSE:DXR), the global leader in blood volume measurement technology, announces today it issued a corporate update in a Letter to Shareholders filed in its certified shareholder report on form N-CSR on
Benzinga · 09/01 12:33
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
Oak Ridge, TN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today it issued a corporate update in a Letter to Shareholders filed in its certified shareholder report on...
GlobeNewswire · 09/01 12:30
Daxor Reports 26.5% Rise In Diagnostic Sales Revenue For 6 Months Ending June 30, 2021
Daxor Corporation (NYSE:DXR), the global leader in blood volume measurement technology, announces today it filed Form N-CSR disclosing its schedule of portfolio holdings for the six months ended June 30, 2021. The
Benzinga · 08/30 12:35
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DXR. Analyze the recent business situations of DAXOR CORP through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DXR stock price target is 22.00 with a high estimate of 22.00 and a low estimate of 22.00.
EPS
Institutional Holdings
Institutions: 4
Institutional Holdings: 79.82K
% Owned: 1.98%
Shares Outstanding: 4.03M
TypeInstitutionsShares
Increased
3
6.30K
New
0
0
Decreased
1
2.00K
Sold Out
3
74.58K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.38%
Healthcare Equipment & Supplies
+0.22%
Key Executives
Chairman/President/Chief Executive Officer/Director
Michael Feldschuh
Chief Financial Officer
Robert Michel
Chief Scientific Officer/Director
Jonathan Feldschuh
Director
Henry Cremisi
Director
Edward Feuer
Independent Director
Joy Goudie
Independent Director
James Lombard
Independent Director
Robert Willens
Declaration Date
Dividend Per Share
Ex-Div Date
12/28/2017
Dividend USD 0.03
01/05/2018
11/18/2016
Dividend USD 0.03
12/20/2016
12/09/2015
Dividend USD 0.04
12/18/2015
11/17/2014
Dividend USD 0.03
12/04/2014
11/15/2013
Dividend USD 0.05
12/05/2013
11/29/2012
Dividend USD 0.1
12/07/2012
08/03/2012
Dividend USD 0.1
08/10/2012
11/08/2011
Dividend USD 0.1
11/16/2011
05/25/2011
Dividend USD 0.15
05/27/2011
11/30/2010
Dividend USD 0.65
12/14/2010
09/02/2010
Dividend USD 0.25
09/13/2010
05/11/2010
Dividend USD 0.1
05/27/2010
--
Dividend USD 1
12/08/2009
--
Dividend USD 0.25
08/21/2009
--
Dividend USD 0.1
05/27/2009
--
Dividend USD 1
12/10/2008
--
Dividend USD 0.25
10/31/2008
--
Dividend USD 0.25
07/24/2008
About DXR
Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company focuses on the development of the Blood Volume Analyzer (BVA) -100, an instrument that rapidly and accurately measures human blood volume. The Company’s instrument is used in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.The Company also owns the Daxor Oak Ridge Operations (DORO) facility in Oak Ridge, Tennessee. The semi-automated BVA provides blood volume measurements in human body for diagnosis and treatment in a range of medical and surgical conditions.

Webull offers kinds of Daxor Corporation stock information, including AMEX:DXR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DXR stock methods without spending real money on the virtual paper trading platform.